713
Views
25
CrossRef citations to date
0
Altmetric
Review

Primary mediastinal lymphoma: diagnosis and treatment options

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Salvatore Perrone, Paolo Lopedote, Mario Levis, Alice Di Rocco & Stephen Douglas Smith. (2022) Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy. Expert Review of Hematology 15:3, pages 215-232.
Read now
Jitender Takyar, Monika Raut, Rebekah Borse, Arun Balakumaran & Manu Sehgal. (2020) Relapsed/refractory primary mediastinal large B-cell lymphoma: a structured review of epidemiology, treatment guidelines and real-world treatment practices. Expert Review of Hematology 13:3, pages 275-287.
Read now
Xiaojian Liu, Ting Deng, Xianzhi Guo, Ye Guo, Leiping Wang, Jian Zhang, Zuguang Xia, Quanling Zhang, Kai Xue, Junning Cao, Jumei Shi & Xiaonan Hong. (2017) A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation. Hematology 22:5, pages 258-264.
Read now

Articles from other publishers (22)

Jia-Jia Huang, Yi Xia, Yu Wang, Pan-Pan Liu, Xi-Wen Bi, Peng Sun, Tong-Yu Lin, Wen-Qi Jiang & Zhi-Ming Li. (2016) A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution . Oncotarget 7:27, pages 41242-41250.
Crossref
Giuseppe Facondo, Mattia Serio, Gianluca Vullo, Maria Paola Bianchi, Sabrina Pelliccia, Alice Di Rocco, Tiziana Lanzolla, Maurizio Valeriani, Arianna Di Napoli, Agostino Tafuri, Maurizio Martelli, Mattia Falchetto Osti & Vitaliana De Sanctis. (2023) Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study. Journal of Clinical Medicine 12:11, pages 3777.
Crossref
Salvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, Ilenia Iamundo De Cumis, Alessandro Pulsoni & Paolo Strati. (2023) Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond. Cancers 15:10, pages 2751.
Crossref
Marie Emilie Dourthe, Aurélie Phulpin, Anne Auperin, Jacques Bosq, Marie-Laure Couec, Peggy Dartigues, Stéphane Ducassou, Nathalie Garnier, Stéphanie Haouy, Thierry Leblanc, Amaury Leruste, Catherine Paillard, Charlotte Rigaud, Mathieu Simonin, Catherine Patte & Véronique Minard-Colin. (2022) Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study. Haematologica 107:9, pages 2173-2182.
Crossref
Stamatis Karakatsanis, Sotirios G. Papageorgiou, Michail Michail, Maria K. Angelopoulou, Christina Kalpadakis, Theoni Leonidopoulou, Eirini Katodritou, Maria Kotsopoulou, Ioannis Kotsianidis, Eleftheria Hatzimichael, Eleftheria Lakiotaki, Dimitrios Boutsis, George Karianakis, Argiris Symeonidis, Maria Gavriatopoulou, Panayiotis Panayiotidis, Kostas Konstantopoulos, Themis Karmiris, Gerassimos A. Pangalis & Theodoros P. Vassilakopoulos. (2021) Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis. Leukemia Research 107, pages 106595.
Crossref
Nidaa Mikail, Antoine Khalil & François Rouzet. (2021) Mediastinal Masses: 18F-FDG-PET/CT Features Based on the International Thymic Malignancy Interest Group Classification. Seminars in Nuclear Medicine 51:1, pages 79-97.
Crossref
R.N. Komarov, V.D. Parshin, S.V. Chernyavsky & A.M. Ismailbaev. (2020) Resection of recurrent hemangioma of the anterior mediastinum with aortic arch replacement and simultaneous resection of left atrial myxoma. Khirurgiya. Zhurnal im. N.I. Pirogova:6, pages 114.
Crossref
Li Xiao‐dong, Zhang Li, Duan Xiu‐mei, Tang Ming‐bo & Wang Xiao‐cong. (2019) Identification of a giant mediastinal teratoma by echocardiography: A case report. Journal of Clinical Ultrasound 47:6, pages 380-383.
Crossref
Neda Kalhor & Cesar MoranNeda Kalhor & Cesar Moran. 2019. Mediastinal Pathology. Mediastinal Pathology 521 577 .
Donald C. Moore, Justin R. Arnall & Dragos C. Plesca. (2018) Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting. American Journal of Health-System Pharmacy 75:22, pages 1824-1830.
Crossref
Yasuhiro Chikaishi, Hiroki Matsumiya, Masatoshi Kanayama, Akihiro Taira, Yusuke Nabe, Shinji Shinohara, Taiji Kuwata, Masaru Takenaka, Soichi Oka, Ayako Hirai, Koji Kuroda, Naoko Imanishi, Yoshinobu Ichiki, Yosuke Nishimura & Fumihiro Tanaka. (2018) Complete resection of an anterior mediastinal tumor by total arch replacement and pulmonary artery trunk plasty with a pericardial patch: A case report. Annals of Medicine and Surgery 35, pages 82-85.
Crossref
Michel Meignan & Anne-Ségolène Cottereau. (2018) FDG-PET in PMBCL: which heterogeneity?. Blood 132:2, pages 117-118.
Crossref
Sindhu Cherian & Jonathan R. Fromm. (2018) Evaluation of primary mediastinal large B cell lymphoma by flow cytometry. Cytometry Part B: Clinical Cytometry 94:3, pages 459-467.
Crossref
E. L. Moore, W. Vernau, R. B. Rebhun, K. A. Skorupski & J. H. Burton. (2018) Patient characteristics, prognostic factors and outcome of dogs with high-grade primary mediastinal lymphoma. Veterinary and Comparative Oncology 16:1, pages E45-E51.
Crossref
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song & Ryan T. Phan. 2018. Atlas of Hematopathology. Atlas of Hematopathology 583 604 .
Vitaliana De Sanctis, Marco Alfò, Alice Di Rocco, Michela Ansuinelli, Eleonora Russo, Mattia F. Osti, Maurizio Valeriani, Giuseppe Minniti, Lavinia Grapulin, Daniela Musio, Stefano Bracci, Alessandra Spagnoli, Maria Luisa Moleti, Vincenzo Tombolini & Maurizio Martelli. (2017) Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results. Hematological Oncology 35:4, pages 554-560.
Crossref
Julien Lazarovici, Marie Terroir, Julia Arfi-Rouche, Jean-Marie Michot, Sacha Mussot, Valentina Florea, Maria-Rosa Ghigna, Peggy Dartigues, Cynthia Petrovanu, Alina Danu, Christophe Fermé, Vincent Ribrag & David Ghez. (2017) Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 44:12, pages 2018-2024.
Crossref
Pier Luigi ZinzaniVincent RibragCraig H. MoskowitzJean-Marie MichotJohn KuruvillaArun Balakumaran, Yayan Zhang, Sabine Chlosta, Margaret A. Shipp & Philippe Armand. (2017) Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma. Blood 130:3, pages 267-270.
Crossref
Gayane Sergeevna Tumyan, I.Z. Zavodnova, M.Yu. Kichigina & E.G. Medvedovskaya. (2017) Primary Mediastinal (Thymic) Large B-Cell Lymphoma. Clinical oncohematology 10:1, pages 13-24.
Crossref
Luca Ceriani, Maurizio Martelli, Maria K. Gospodarowicz, Umberto Ricardi, Andrés J.M. Ferreri, Annalisa Chiappella, Caterina Stelitano, Monica Balzarotti, Maria E. Cabrera, David Cunningham, Attilio Guarini, Pier Luigi Zinzani, Luca Giovanella, Peter W.M. Johnson & Emanuele Zucca. (2017) Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics 97:1, pages 42-49.
Crossref
Seth J. Kligerman, Teri J. Franks & Jeffrey R. Galvin. (2016) Primary Extranodal Lymphoma of the Thorax. Radiologic Clinics of North America 54:4, pages 673-687.
Crossref
Franco CavalliLuca CerianiEmanuele Zucca. (2016) Functional Imaging Using 18-Fluorodeoxyglucose PET in the Management of Primary Mediastinal Large B-Cell Lymphoma: The Contributions of the International Extranodal Lymphoma Study Group. American Society of Clinical Oncology Educational Book:36, pages e368-e375.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.